• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

下半身体重较轻和女性性别:使用磷酸钠盐制剂后的高磷血症风险因素。

Lower body weight and female gender: hyperphosphatemia risk factors after sodium phosphate preparations.

出版信息

World J Gastroenterol. 2011 Jun 7;17(21):2681-2. doi: 10.3748/wjg.v17.i21.2681.

DOI:10.3748/wjg.v17.i21.2681
PMID:21677840
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3110934/
Abstract

Casais et al have reported an inverse correlation between serum phosphate and body weight after administration of sodium phosphate at a dose of 60 g. Our group has already described the relationship between body weight and hyperphosphatemia with these preparations, although our study was not quoted by Casais. We performed a pharmacokinetic study involving 13 volunteers who were divided into two groups on the basis of body weight: group I consisting of seven women with a median weight of 60 kg and group II consisting of five men and one woman with a median weight of 119.2 kg. Group I developed higher peak phosphate levels and maintained these levels above the subjects in Group II for a prolonged time period despite adequate hydration being ensured with frequent monitoring of weight, fluid intake and total body weight. Our study demonstrated that adequate hydration does not protect against the secondary effects of hyperphosphatemia. In the study by Casais et al, 66% of the study subjects were women, the correlation between serum phosphate and gender in their data also appears to be important. Women are at higher risk of acute phosphate nephropathy due to a diminished volume of distribution of the high dose of ingested phosphate. Decreased volume of distribution in women is due to diminished body weight. This is further compounded by decreased creatinine clearance in females.

摘要

卡斯泰尔斯等人报告称,在给予 60 克磷酸钠后,血清磷酸盐与体重呈负相关。我们的研究小组已经描述了这些制剂与体重和高磷酸盐血症之间的关系,尽管我们的研究未被卡斯泰尔斯引用。我们进行了一项涉及 13 名志愿者的药代动力学研究,根据体重将志愿者分为两组:I 组包括 7 名体重中位数为 60 公斤的女性,II 组包括 5 名男性和 1 名体重中位数为 119.2 公斤的女性。尽管通过频繁监测体重、液体摄入量和总体重来确保充足的水合作用,但 I 组的志愿者峰值磷酸盐水平更高,且这些水平维持的时间也比 II 组长。我们的研究表明,充足的水合作用并不能防止高磷酸盐血症的继发性影响。在卡斯泰尔斯等人的研究中,66%的研究对象为女性,他们的数据中血清磷酸盐与性别之间的相关性似乎也很重要。由于摄入的高剂量磷酸盐分布容积减少,女性发生急性磷酸盐肾病的风险更高。女性分布容积减少是由于体重减轻所致。女性的肌酐清除率降低进一步加剧了这种情况。

相似文献

1
Lower body weight and female gender: hyperphosphatemia risk factors after sodium phosphate preparations.下半身体重较轻和女性性别:使用磷酸钠盐制剂后的高磷血症风险因素。
World J Gastroenterol. 2011 Jun 7;17(21):2681-2. doi: 10.3748/wjg.v17.i21.2681.
2
Hyperphosphatemia after sodium phosphate laxatives in low risk patients: prospective study.低危患者应用磷酸钠盐导泻后发生高磷血症:前瞻性研究。
World J Gastroenterol. 2009 Dec 21;15(47):5960-5. doi: 10.3748/wjg.15.5960.
3
Increased serum phosphate levels and calcium fluxes are seen in smaller individuals after a single dose of sodium phosphate colon cleansing solution: a pharmacokinetic analysis.单次给予磷酸钠结肠清洁剂后,较小个体的血清磷酸盐水平和钙通量增加:一项药代动力学分析。
Aliment Pharmacol Ther. 2009 Jun 1;29(11):1202-11. doi: 10.1111/j.1365-2036.2009.03987.x. Epub 2009 Feb 27.
4
Severe hyperphosphatemia after oral laxative administration in a 7-year-old patient.
Turk J Pediatr. 2016;58(1):116-118. doi: 10.24953/turkjped.2016.01.020.
5
Massive hyperphosphatemia in a patient with neuronal intestinal dysplasia after bowel preparation with oral sodium phosphate.口服磷酸钠肠道准备后,神经元肠发育不良患者出现严重高磷血症。
Ren Fail. 2013 Jul;35(6):875-8. doi: 10.3109/0886022X.2013.794704. Epub 2013 May 28.
6
Severe hyperphosphatemia after administration of sodium-phosphate containing laxatives in children: case series and systematic review of literature.儿童服用含磷酸钠泻药后出现严重高磷血症:病例系列及文献系统综述
Pediatr Surg Int. 2012 Aug;28(8):805-14. doi: 10.1007/s00383-012-3124-4.
7
Renal risks of sodium phosphate tablets for colonoscopy preparation: a review of adverse drug reactions reported to the US Food and Drug Administration.结肠镜检查准备用磷酸钠片剂的肾脏风险:美国食品和药物管理局报告的不良反应综述。
Colorectal Dis. 2011 Sep;13(9):e270-5. doi: 10.1111/j.1463-1318.2011.02679.x.
8
Severe hyperphosphatemia induced by a phosphate-containing oral laxative.含磷酸盐的口服泻药引起的严重高磷血症。
Ann Pharmacother. 1996 Feb;30(2):141-3. doi: 10.1177/106002809603000206.
9
Age as a predictor of hyperphosphatemia after oral phosphosoda administration for colon preparation.年龄作为口服磷酸钠溶液用于结肠准备后高磷血症的预测因素。
J Gastroenterol Hepatol. 2004 Jan;19(1):68-72. doi: 10.1111/j.1440-1746.2004.03253.x.
10
[Acute phosphate nephropathy secondary to the use of oral sodium phosphate laxatives. Report of one case].[口服磷酸钠缓泻剂继发急性磷酸盐肾病。1例报告]
Rev Med Chil. 2021 Jun;149(6):934-938. doi: 10.4067/s0034-98872021000600934.

本文引用的文献

1
Calcium phosphate nephropathy from colonoscopy preparations: effect of body weight.
Am J Gastroenterol. 2010 Mar;105(3):705. doi: 10.1038/ajg.2009.677.
2
Hyperphosphatemia after sodium phosphate laxatives in low risk patients: prospective study.低危患者应用磷酸钠盐导泻后发生高磷血症:前瞻性研究。
World J Gastroenterol. 2009 Dec 21;15(47):5960-5. doi: 10.3748/wjg.15.5960.
3
Acute phosphate nephropathy.急性磷酸盐肾病。
Kidney Int. 2009 Nov;76(10):1027-34. doi: 10.1038/ki.2009.308. Epub 2009 Aug 12.
4
Increased serum phosphate levels and calcium fluxes are seen in smaller individuals after a single dose of sodium phosphate colon cleansing solution: a pharmacokinetic analysis.单次给予磷酸钠结肠清洁剂后,较小个体的血清磷酸盐水平和钙通量增加:一项药代动力学分析。
Aliment Pharmacol Ther. 2009 Jun 1;29(11):1202-11. doi: 10.1111/j.1365-2036.2009.03987.x. Epub 2009 Feb 27.
5
Pathogenesis of nephrocalcinosis after sodium phosphate catharsis to prepare for colonoscopy: Intestinal phosphate absorption and its effect on urine mineral and electrolyte excretion.结肠镜检查前使用磷酸钠泻药后发生肾钙质沉着症的发病机制:肠道磷吸收及其对尿矿物质和电解质排泄的影响。
Hum Pathol. 2007 Jan;38(1):193-4; author reply 194-5. doi: 10.1016/j.humpath.2006.10.008.